Company news, research breakthroughs, and major announcements across industries.

Home/Science

Science

101 Therapeutics to Present Phase 2/3 Data on Macrophage-Targeted, Steroid-Sparing Glucocorticoid 101-PGC-005 at ACR Convergence 2026

101-Therapeutics-Logo.jpg
101-Therapeutics-Logo.jpg

CD206-targeted glucocorticoid 101-PGC-005 beat dexamethasone in 309-patient Phase 2/3 trial (HR 2.31); steroid-sparing data at ACR Poster 0122, Nov 8...

  • PublishedOctober 20, 2026 · 2:46 PM
  • LocationENGLEWOOD, N.J.
  • IndustryScience
  • LanguageEN

Published by Business Wire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization